Results 211 to 220 of about 32,658 (245)

Alpha-7 nicotinic agonist improves cognition in schizophrenia

Evidence Based Mental Health, 2016
ABSTRACT FROM: Keefe RS, Meltzer HA, Dgetluck N, et al . Randomized, double-blind, placebo-controlled study of encenicline, an α7 nicotinic acetylcholine receptor agonist, as a treatment for cognitive impairment in schizophrenia. Neuropsychopharmacology 2015;40:3053–60.
openaire   +2 more sources

Agonist efficiency in a nicotinic receptor

Biophysical Journal, 2023
Dinesh Indurthi, Anthony Auerbach
openaire   +1 more source

Integrative oncology: Addressing the global challenges of cancer prevention and treatment

Ca-A Cancer Journal for Clinicians, 2022
Jun J Mao,, Msce, Lorenzo Cohen, Karen M Mustian   +2 more
exaly  

S5‐01–02: Nicotine and nicotine agonists

Alzheimer's & Dementia, 2008
openaire   +1 more source

Alpha-7 Nicotinic Agonists

2021
openaire   +1 more source

Nicotinic Agonists and Antagonists

2010
Anne M Andrews, Greg A Gerhardt, Lynette C. Daws, Mohammed Shoaib, Barbara J Mason, Charles J Heyser, Luis De Lecea, Robert L Balster, Sharon Walsh, Megan M. Dahmen, Jana Lincoln, Sheldon Preskorn, Roshan Cools, Maria Isabel Colado, Richard Green, Luis Stinus, Stéphanie Caillé, Martine Cador, Marie-Louise G. Wadenberg, Samuel G. Siris, Seiya Miyamoto, Alex Hofer, Linda P Spear, A. Claudio Cuello, A. Leslie Morrow, Patrizia Porcu, Marilyn E Carroll, Peter A Santi, Daniel Bertrand, Hans Rollema, Raymond S Hurst, Peter Riederer, Siegfried Hoyer, Wiepke Cahn, Heleen B M Boos, H D Postma, R. H. De Rijk, E. R Kloet, Sharon Morein-Zamir, Barbara J Sahakian, Peter Riederer, Siegfried Hoyer, J. M. Bessa, Osborne F. X. Almeida, N. Sousa, Wiepke Cahn, Heleen B M Boos, H D Postma, R. Andrew Chambers, Caroline Cohen, Marc Turiault, Guy Griebel, Caroline Cohen, Marc Turiault, Guy Griebel, Wolfgang Fleischhacker, Alfonso Abizaid, Shimon Amir, Jaanus Harro, Peter Verheart, Per Svenningsson, Per Andrén, R. Andrew Chambers, Kenneth J. Rhodes, A. Richard Green, Maria Isabel Colado, Maria Isabel Colado, Richard Green, Christof Baltes, Thomas Mueggler, Markus Rudin, Lucy C. Guillory, Becky Kinkead, Charles B. Nemeroff, Wiepke Cahn, Heleen B M Boos, H D Postma, Heleen B. M. Boos, H. D. Postma, Wiepke Cahn, Stephen B. Dunnett, Michael J Kuhar, Anne M Andrews, Greg A Gerhardt, Lynette Daws, Stephen Stahl, Meghan M Grady, Jean-Michel Scherrmann, Arthur Christopoulos, Gregory D Stewart, Patrick M Sexton, Jelena Nesic, Theodora Duka, Paul B.S. Clarke, Maxine L. Stitzer, Daniel Bertrand, Hans Rollema, Raymond S Hurst, Hans Rollema, Daniel Bertrand, Raymond S. Hurst, Paul Newhouse, Heather Wilkins, Lance Richard McMahon, Trevor W. Robbins, Robert L Balster, Robert L Balster, Patrizia Porcu, A Leslie Morrow, Becky Kinkead, Charles B Nemeroff, Lucy C Guillory, Stephen C Fowler, Jaime M. Monti, Daniel Monti, Malcolm Lader, Seithikurippu R Pandi-Perumal, Milton Kramer, Michael J Thorpy, Shelby Freedman Harris, D Warren Spence, Peter J Tyrer, Linda A Dykstra, Brian E. Leonard, E C Warburton, Michael Minzenberg, Michael Minzenberg, Ian Stolerman, Anne Jackson, Susan Jones, Ben J Harrison, Christos Pantelis, Tara L White, Richard Depue, Michael Bloch, James F Leckman, Christoph Correll   +136 more
openaire   +1 more source

Subtype selective nicotine agonists

European Neuropsychopharmacology, 2000
openaire   +1 more source

Nicotinic Agonists and Antagonists

2014
Hans Rollema, Daniel Bertrand, Raymond S. Hurst   +2 more
openaire   +1 more source

Nicotinic agonists for Alzheimer therapy

Neurobiology of Aging, 2014
openaire   +1 more source

[32] Pharmacophore for nicotinic agonists

1991
T.M. Gund, C.E. Spivak
openaire   +1 more source